Results 121 to 130 of about 28,723 (210)

Weight-based, anti-Xa guided enoxaparin after spine trauma surgery: target attainment and safety in a retrospective cohort. [PDF]

Front Surg
Sheinberg DL, Johnston DT, O'Reilly BT, Castro GG, Khazaal JR, Withrow JS, Trimble DJ, Chandra A, Lim AJ, Sheinberg DS, Zaragoza J, Li W, Williams JR.   +12 more
europepmc   +1 more source

Post-discharge VTE prophylaxis after bariatric surgery: balancing bleeding risk and thrombosis prevention in 275,843 patients. [PDF]

Surg Endosc
Gillikin AP, Rabinovich EP, Barajas-Gamboa JS, Mocanu V, Dang JT, Carter C, Hallowell P, Schirmer B, Shin TH.   +8 more
europepmc   +1 more source

Real-World Safety and Circuit Outcomes of Protocolized Divided-Dose Enoxaparin During Continuous Renal Replacement Therapy Without Routine Anti-Xa Monitoring: A Single-Center Competing-Risk Cohort Study. [PDF]

J Clin Med
Toprak HB, Taşkın G, Bayrak MA, Sallan M, Kocakanat O, Erdemir M, Yamanel L.   +6 more
europepmc   +1 more source

Effects of hydroxychloroquine sulfate combined with aspirin and enoxaparin sodium therapy on perinatal outcomes in patients with undifferentiated connective tissue disease-related recurrent miscarriage: a retrospective clinical study. [PDF]

BMC Pregnancy Childbirth
Pei LC, Wang T, Guo YJ, Yang QL, Liu WD, Jiang CW, Yan PC, Li XJ, Wang CJ.   +8 more
europepmc   +1 more source

Spontaneous chest wall hematoma as a rare complication of anticoagulant and antiaggregant therapy. [PDF]

Ulus Travma Acil Cerrahi Derg
Kış A, Öztürk G, Aydoğmuş Ü.
europepmc   +1 more source

Venous Thromboembolism and Bleeding Risk in a Population with Obesity Hospitalized for Surgery and Receiving Enoxaparin for Thromboprophylaxis. [PDF]

Obes Surg
Ageno W, Carrier M, Stroh C, Djoudi Y, Abdel-Moneim M, Khan I, Ponomareva E.   +6 more
europepmc   +1 more source

Postprocedural Anticoagulation After Primary Percutaneous Coronary Intervention: 1-Year Results From the RIGHT Trial and Meta-analyses. [PDF]

JACC Asia
Yan Y, Wang X, Fan Z, Guo J, Wang G, Yin D, Wang Z, Zhang F, Tian C, Gong W, Liu J, Lu J, Ma C, Vicaut E, Montalescot G, Nie S, RIGHT Investigators.   +16 more
europepmc   +1 more source

Enoxaparin Dosing and Target anti-Factor Xa Achievement in Infants by Postmenstrual Age. [PDF]

J Pediatr Pharmacol Ther
Perez D, Mathew K.
europepmc   +1 more source

Venous thromboembolic and bleeding risk in population with obesity hospitalized for an acute medical illness receiving enoxaparin for thromboprophylaxis. [PDF]

Res Pract Thromb Haemost
Ageno W, Arcelus JI, Stroh C, Djoudi Y, Abdel-Moneim M, Khan I, Ponomareva E, Carrier M.   +7 more
europepmc   +1 more source

Enoxaparin, Tinzaparin, and Apixaban Modulate Cancer Cell Procoagulant Activity and Viability: Comparison with Quercetin. [PDF]

Cancers (Basel)
Baghdadi MA, do Carmo Las Casas PHF, Mbemba E, Rousseau A, Kempaiah P, Svistunov AA, Bitsadze V, Sabbah M, Fareed J, Van Dreden P, Trachana V, Lefkou E, Gerotziafas G.   +12 more
europepmc   +1 more source